"The
Report Ulcerative Colitis Global Clinical Trials Review, H2, 2016
provides information on pricing, market analysis, shares, forecast,
and company profiles for key industry participants. -
MarketResearchReports.biz"
GlobalData's
clinical trial report, Ulcerative
Colitis
Global Clinical Trials Review, H2, 2016" provides an overview of
Ulcerative Colitis clinical trials scenario. This report provides top
line data relating to the clinical trials on Ulcerative Colitis.
Report includes an overview of trial numbers and their average
enrollment in top countries conducted across the globe. The report
offers coverage of disease clinical trials by region, country (G7 &
E7), phase, trial status, end points status and sponsor type. Report
also provides prominent drugs for in-progress trials (based on number
of ongoing trials). GlobalData Clinical Trial Reports are generated
using GlobalDatas proprietary database - Pharma eTrack Clinical
trials database. Clinical trials are collated from 80+ different
clinical trial registries, conferences, journals, news etc across the
globe. Clinical trials database undergoes periodic update by dynamic
process.
The
report enhances the decision making capabilities and helps to create
an effective counter strategies to gain competitive advantage.
Get
Sample copy of this Report @
http://www.marketresearchreports.biz/sample/sample/855955
Scope
-
The report provides a snapshot of the global clinical trials
landscape
-
Report provides top level data related to the clinical trials by
Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor
Type and End point status
-
The report reviews top companies involved and enlists all trials
(Trial title, Phase, and Status) pertaining to the company
-
The report provides all the unaccomplished trials (Terminated,
Suspended and Withdrawn) with reason for unaccomplishment
-
The Report provides enrollment trends for the past five years
-
Report provides latest news for the past three months
Reasons
to buy
-
Assists in formulating key business strategies with regards to
investment
-
Helps in identifying prominent locations for conducting clinical
trials which saves time and cost
-
Provides top level analysis of Global Clinical Trials Market which
helps in identifying key business opportunities
-
Supports understanding of trials count and enrollment trends by
country in global therapeutics market
-
Aids in interpreting the success rates of clinical trials by
providing a comparative scenario of completed and uncompleted
(terminated, suspended or withdrawn) trials
-
Facilitates clinical trial assessment of the indication on a global,
regional and country level
Read
our latest Press Release at
http://www.marketresearchreports.biz/pressreleases
Table
of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average
Enrollment by Country 7
Top Five Countries Contributing
to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing
to Clinical Trials in Europe 10
Top Countries Contributing to
Clinical Trials in North America 11
Top Five Countries Contributing
to Clinical Trials in Middle East and Africa 12
Top Five Countries Contributing
to Clinical Trials in Central and South America 13
Clinical Trials by G7
Countries: Proportion of Ulcerative Colitis to Gastrointestinal
Clinical Trials 14
Clinical Trials by Phase in G7
Countries 15
Clinical Trials in G7 Countries
by Trial Status 16
Clinical Trials by E7
Countries: Proportion of Ulcerative Colitis to Gastrointestinal
Clinical Trials 17
Clinical Trials by Phase in E7
Countries 18
Clinical Trials in E7 Countries
by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status
22
Clinical Trials by End Point
Status 23
Subjects Recruited Over a
Period of Time 24
Clinical Trials by Sponsor Type
25
Prominent Sponsors 26
Top Companies Participating in
Ulcerative Colitis Therapeutics Clinical Trials 27
Prominent Drugs 29
Latest Clinical Trials News on
Ulcerative Colitis 30
Sep 21, 2016: Gilead Terminates
Phase 2/3 Study of GS-5745 in Patients With Ulcerative Colitis 30
Sep 16, 2016: Favorable
Benefit: Risk Profile for Vedolizumab as Induction and Maintenance
Therapy in TNF-Nave or TNF-Failure Patients with Moderately to
Severely Active Ulcerative Colitis Published in Clinical
Gastroenterology and Hepatology 30
Aug 22, 2016: Lycera Announces
Initiation of Phase 2 Clinical Trial of LYC-30937-EC in Patients with
Ulcerative Colitis 31
Jul 28, 2016: Pfizer Announces
Positive Top-Line Results from Pivotal Phase 3 Maintenance Trial of
Oral XELJANZ (Tofacitinib Citrate) in Ulcerative Colitis 32
Jul 13, 2016: InDex
Pharmaceuticals publishes results from COLLECT study 33
Clinical Trial Profile
Snapshots 34
Appendix 494
Abbreviations 494
Definitions 494
Research Methodology 495
Secondary Research 495
About GlobalData 496
Contact Us 496
Disclaimer 496
Source 497
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-618-1030
USA:
Canada Toll Free: 866-997-4948
No comments:
Post a Comment